We are pleased to announce the appointment of John Fox, MD, MHA, as Chair of ACGP. Dr. Fox is currently the Senior Medical Director of the Americas, Market Access, for Illumina, where he is accountable for working with payers and employers to expand access to genomic testing for cancer, rare and infectious diseases, and cardiac and prenatal applications.
“Genomics continues to transform the practice of oncology which translates into improved outcomes and better value—but only if providers can access and accurately apply the technology. I look forward to working with fellow members of ACGP to make the promise of comprehensive genomic profiling a tangible benefit to the patients we serve.” – Dr. John Fox